Latest Breaking News On - Recurrent pericarditis - Page 1 : comparemela.com

Can Growing Adoption Of Arcalyst Drive KNSA Stock Up?

Kiniksa Pharmaceuticals Ltd.'s (KNSA) flagship product Arcalyst has garnered widespread acclaim and acceptance since its launch in April 2021. With a growing adoption rate, the company has revised upward its revenue forecast for 2024.

Kiniksa pharmaceuticals ltdKiniksa pharmaceuticalsNasdaq global select marketRecurrent pericarditisJögrens disease

Cardiol Therapeutics Announces Year-End 2023 Update On Operations

Cardiol Therapeutics Announces Year-End 2023 Update On Operations
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesTrevor burnsDavid elsleyEuropean unionAmerican heart association scientific sessionsWorld congressUniversity of virginiaMenafn newsfile corpHeart failure society of americaDrug administrationHouston methodist debakey heart vascular centerAmerican college of cardiologyCompany phaseCardiol therapeutics incCompany annual report on formNewsfile corp

Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Portfolio Execution

Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Portfolio Execution
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Rachel frankSanjk patelAmerican college of cardiology scientific sessionRegeneron pharmaceuticals incDrug administrationExchange commissionKiniksa pharmaceuticals ltdRoche groupGlobenewswire incEuropean commissionAbiprubart phaseChief executive officerRilonacept utilizationSteroid sparing paradigmRecurrent pericarditisCardiology scientific session

Cardiol Therapeutics Announces Massachusetts General Hospital, Largest Teaching Hospital of Harvard Medical School, as the 8th Major Medical Centre Participating in MAvERIC-Pilot

Cardiol Therapeutics Announces Massachusetts General Hospital, Largest Teaching Hospital of Harvard Medical School, as the 8th Major Medical Centre Participating in MAvERIC-Pilot
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesAllanl kleinAndrew hamerTrevor burnsVascular instituteCompany annual report on formCardiol therapeutics incCompany phaseDrug administrationNewsfile corpHead of research developmentRecurrent pericarditisComplete patient recruitmentMassachusetts general hospitalCardiol therapeutic chief medical officerMass general

Cardiol Therapeutics Inc : Cardiol Therapeutics Announces Massachusetts General Hospital, Largest Teaching Hospital of Harvard Medical School, as the 8th Major Medical Centre Participating in MAvERIC-Pilot

Cardiol Therapeutics Inc : Cardiol Therapeutics Announces Massachusetts General Hospital, Largest Teaching Hospital of Harvard Medical School, as the 8th Major Medical Centre Participating in MAvERIC-Pilot
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesAllanl kleinTrevor burnsStefan klotterAndrew hamerNewsfile corpVascular instituteCompany phaseDrug administrationCardiol therapeutics incHead of research developmentCompany annual report on formRecurrent pericarditisComplete patient recruitmentMassachusetts general hospitalCardiol therapeutic chief medical officer